Immuthera is pioneering novel cell-based therapies for clinical development in the United States and Canada. Immuthera will be clinically developing assets initially developed by PolTREG under the US FDA regulatory framework. Immuthera will have full access to PolTREG’s Research and Development capabilities along with the ability to explore novel modalities developed by US Institutions. Immuthera is currently seeking investment to pursue the manufacture and clinical development of these assets in the United States.

Immuthera

Piotr Trzonkowski

This department provides strategic direction and oversees the overall management of the organization.

Immuthera

Org chart

Teams

Executive Leadership

Offices

Immuthera

Org chart

Teams

Executive Leadership

Offices

Related companies